MedicarePartD.guide

A non-government resource built from CMS public data

Overactive bladder drugs on Blue Cross MedicareRx Basic (S5715-013)

Oxybutynin, solifenacin, Myrbetriq and Gemtesa, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), New Mexico
Premium
$145.40/month
Deductible
$615.00
Change plan

3 of 7 Overactive bladder drugs are covered on this plan. None require prior authorization.

4 aren't on the formulary, including solifenacin and mirabegron.

Not on the formulary
solifenacin, mirabegron, Gemtesa, trospium

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list